Ask AI

Bridging Cancer Discoveries to Practice: CCO’s Independent Conference Highlights From the ESMO 2025 Congress *

Gain expert insights into recent clinical trial data on novel approaches and emerging therapies presented at the ESMO 2025 Congress to personalize care and improve outcomes of patients with solid tumors including breast cancer, lung cancer, and gastrointestinal cancers through a preconference ClinicalThought commentary and, following the meeting, downloadable slides of the key studies and certified text modules with expert viewpoints on the implications of the different studies.

Share

Program Content

Activities

ESMO 2025 Preview
An Expert’s Guide to ESMO 2025: A Preview of the Top Abstracts
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: October 16, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., Gilead Sciences, Inc., Incyte, and Lilly.

AstraZeneca

Daiichi Sankyo, Inc.

Gilead Sciences, Inc.

Incyte

Lilly

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.